Retrospective Observational Study Using the QOL Scale for Rebamipde Ophthalmic Suspension Treatment in the Dry Eye Syndrome Patient

Trial Profile

Retrospective Observational Study Using the QOL Scale for Rebamipde Ophthalmic Suspension Treatment in the Dry Eye Syndrome Patient

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Rebamipide (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 10 Jan 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 19 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top